Nissen Peter H, Campbell Nina Buntzen, Højskov Carsten S, Fløe Andreas, Hoffmann Hans Jürgen, Hilberg Ole, Ladefoged Søren A, Møller Holger J
Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark
Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus, Denmark.
Ann Clin Biochem. 2015 Jan;52(Pt 1):105-12. doi: 10.1177/0004563214529261. Epub 2014 Apr 2.
The serum-angiotensin I converting enzyme (s-ACE) activity is influenced by a genetic insertion/deletion (I/D) polymorphism in the ACE gene, and the resulting large interindividual variation in s-ACE limits the use of normal reference intervals in the evaluation of sarcoidosis. In this study, we developed a new method for genotyping the I/D polymorphism in ACE and established genotype-specific reference intervals in order to improve the diagnostic accuracy and the value for treatment of sarcoidosis.
The new genotyping assay is based on high-resolution melting (HRM) using LCGreen + and was used to genotype 400 healthy Danish individuals. The assay was compared to a real-time polymerase chain reaction (RT-PCR) assay in a validation set of 86 samples. Enzyme activity in serum was measured using the Infinity™ ACE Liquid Stable Reagent from Thermo adapted for the ABX Pentra analyzer.
There was full concordance between genotyping assays. The three genotypes II, ID and DD were present with a frequency of 0.23, 0.51 and 0.26. The distribution of s-ACE values in the total population was non-Gaussian (non-parametric 95% reference interval 12.0-60.0 U/L). The median activities of the genotypes differed significantly (P<0.0001). Ninety-five per cent non-parametric reference intervals for the subpopulations were determined to 6.3-38.5, 14.0-56.0 and 23.3-71.2 U/L for II, ID and DD, respectively.
We have developed a simple and robust method for ACE genotyping and determined genotype-specific reference intervals for s-ACE concentrations in the Danish population. The new reference intervals may increase the value of s-ACE measurements.
血清血管紧张素I转换酶(s-ACE)活性受ACE基因中一个基因插入/缺失(I/D)多态性的影响,s-ACE个体间的巨大差异限制了正常参考区间在结节病评估中的应用。在本研究中,我们开发了一种新的ACE基因I/D多态性基因分型方法,并建立了基因型特异性参考区间,以提高结节病的诊断准确性和治疗价值。
新的基因分型检测基于使用LCGreen +的高分辨率熔解(HRM),并用于对400名丹麦健康个体进行基因分型。在86个样本的验证集中,将该检测方法与实时聚合酶链反应(RT-PCR)检测方法进行比较。使用适用于ABX Pentra分析仪的赛默飞世尔公司的Infinity™ ACE液体稳定试剂测量血清中的酶活性。
基因分型检测之间完全一致。三种基因型II、ID和DD的出现频率分别为0.23、0.51和0.26。总人群中s-ACE值的分布呈非高斯分布(非参数95%参考区间为12.0 - 60.0 U/L)。各基因型的中位活性差异显著(P<0.0001)。II、ID和DD亚组人群的95%非参数参考区间分别确定为6.3 - 38.5、14.0 - 56.0和23.3 - 71.2 U/L。
我们开发了一种简单且可靠的ACE基因分型方法,并确定了丹麦人群中s-ACE浓度的基因型特异性参考区间。新的参考区间可能会提高s-ACE测量的价值。